Anders Schultz, MD, FRCPC Edmonton, AB, Canada Send page to friend via: Share via:

semaglutide) Baseline assessments of drinking patterns and health markers Introduction to complementary app-based support systems Begin medication regimen under medical supervision Initiate daily app-based tracking and coaching Utilize 24/7 in-app coaching features for real-time support Regular medical check-ins to monitor medication effectiveness and side effects Adjust medication dosing based on response and app-tracked data Leverage peer support community features for long-term motivation Continue evidence-based behavior change program elements Ongoing medical monitoring with app data integration While semaglutide shows promise for alcohol reduction, users must be vigilant for potential side effects: Severe nausea or vomiting that prevents medication adherence Signs of pancreatitis (severe abdominal pain, nausea, vomiting) Unusual changes in mood or mental health status Significant changes in blood sugar levels (for diabetic patients) Allergic reactions or injection site complications Naltrexone users should watch for: Liver function abnormalities (yellowing of skin/eyes, dark urine) Severe mood changes or depression Unusual fatigue or weakness Gastrointestinal distress that doesn't improve Any signs of opioid withdrawal (if opioids were previously used) Reframe's daily logging and progress tracking features can help identify concerning patterns early

The protocol typically includes weekly injections, nutritional support, and follow-up appointments every six weeks to monitor progress
The rise of telehealth and direct-to-consumer platforms is also reshaping the dispensing landscape, with some patients receiving drugs through mail-order pharmacies or digital health platforms
The physician can't separately bill the administration code in a facility setting
FAQs Semaglutide is ideal for individuals with a body mass index (BMI) of 30 or greater or for adults with a BMI of 27 who also have at least one weight-related complication such as hypertension, insulin resistance, high cholesterol, or heart disease